[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
VoractivSee online BNFApproved April 2016 as per licensed indication for treatment of Mycobacterium Tuberculosis via ICU consultants.   
0.1% Topical Sirolimus 0.1% ointment See online BNFTo treat angiofibromas in patients that have partial or no response to laser treatment.  Clinically approved December 2015 as per indication for Dermatology Consultants.    
Abatacept10.1.3 Drugs that suppress the rheumatic disease process - Cytokine modulatorsApproved July 2012 for moderate to severe RA, in line with NICE guidance by rheumatology. https://www.nice.org.uk/guidance/ta195  
Abciximab2.9 Antiplatelet drugsOff label use - Radiology and Neurosciences directorates only. Use by consultant cardiologist in line with NICE CG 94 - 
Abiraterone8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonistsIn line with NICE -a recommended option for metastatic prostate cancer after testosterone reduction therapy and docetaxel. 
Abiraterone See online BNFApproved March 2013 - For pre-chemotherapy patients with funding authorised by the Cancer Drug Fund.   
Acenocoumarol2.8.2 Oral anticoagulantsHaematology and Oncology only 
Acetazolamide 250mg Modified Release Tablets11.6 Treatment of glaucomaApproved for use for initiation by eye consultants.   Approved Jan 2014 by MMG  
Acetazolamide 250mg Tablets11.6 Treatment of Glaucoma  
Acetic acid (Aci-Jel)7.2.2 Anti-infective drugs  


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.